ArticleNature communications2021

The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.

Min Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.